跳至主要内容
临床试验/NCT05786534
NCT05786534Enrolling By Invitation不适用

Therapeutic Potential of Green Seaweed, Ulva Lactuca, Against Metabolic Syndrome

University of Veterinary and Animal Sciences, Lahore - Pakistan2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年12月9日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
40
试验地点
2
主要终点
Blood pressure will be assessed before and after the trial

研究概览

简要总结

Metabolic syndrome is a major concern worldwide and in Pakistan as well. Metabolic syndrome is a pathologic condition which includes abdominal obesity, insulin resistance, hypertension and hyperlipidemia. Seafood consumption has been linked to reduced risk of many health conditions including altered blood profile. Green seaweed is known to have a potential in optimizing the blood profile and so, it is helpful in reducing the risk of metabolic syndrome by playing a role in preventing obesity, hyperglycemia, high blood pressure and altered lipid profile. Green seaweed (Ulva Lactuca) powder will prove to have therapeutic potential against obesity, hypertension, glucose intolerance and dyslipidemia.

详细描述

Metabolic syndrome is a major concern worldwide and in Pakistan as well. Metabolic syndrome is a pathologic condition which includes abdominal obesity, insulin resistance, hypertension and hyperlipidemia. Seafood consumption has been linked to reduced risk of many health conditions including altered blood profile. Green seaweed is known to have a potential in optimizing the blood profile and so, it is helpful in reducing the risk of metabolic syndrome by playing a role in preventing obesity, hyperglycemia, high blood pressure and altered lipid profile.

Statement of problem: The number of people with high LDL-cholesterol, body mass index and fasting plasma glucose levels has been increasing. These factors are promoting the risk of metabolic syndrome in Pakistan. 26-38% people in Pakistan are reported to be a patient of metabolic syndrome. Seaweed has shown to be protective against the syndrome in previous studies. The goal of this study is to check the role of green seaweed against metabolic syndrome.

Hypothesis: Green seaweed (Ulva Lactuca) has a potential to manage metabolic syndrome.

Objective: To assess the therapeutic effect of green seaweed (Ulva Lactuca) against metabolic syndrome.

Methodology: Green seaweed powder will be procured from Taokaenoi Food and Marketing Public Co., Ltd. (Thailand). The proximate analysis of the product will be performed and then capsules of powder will be prepared to be consumed by the participants. Total 40 subjects (20 in treatment group and 20 in control group) will be selected and green seaweed powder will be added in their diets (200mg twice a day). After a trial of 40 days, the patients will be assessed. Assessment will include anthropometric measurements, blood pressure, lipid profile analysis and total antioxidant capacity (TAC) which will be monitored before and after the trial and final,ly, the data collected will be analyzed by using SPSS 25 by paired sample t test. P value ≤ 0.05 will be considered significant.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

盲法说明

Participants groups

入排标准

年龄范围
35 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • BMI > 25kg/m2
  • Dyslipidemia
  • Altered blood glucose level
  • Age 30-55 ( male and female)

排除标准

  • Thyroid disorder
  • Liver disease
  • Kidney disorder
  • Cancer etc

结局指标

主要结局

Blood pressure will be assessed before and after the trial

时间窗: 40 days

The change in blood pressure, after consuming green seaweed powder for 40 days, will be assessed. The values will become close to optimized levels.

Weight will be measured before and after the trial

时间窗: 40 days

The change in weight will be measured, after consuming green seaweed powder for 40 days. BMI will become close to normal range.

Fasting glucose level will be assessed before and after the trial

时间窗: 40 days

The change in fasting glucose levels will be assessed, after consuming green seaweed powder for 40 days. The values will become close to optimized levels.

Lipid profile will be assessed before and after the trial

时间窗: 40 days

The improvement in lipid profile, after consuming green seaweed powder for 40 days, will be assessed. The values will become close to optimized values.

次要结局

未报告次要终点

研究者

发起方
University of Veterinary and Animal Sciences, Lahore - Pakistan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Asif Ali

Researcher

University of Veterinary and Animal Sciences, Lahore - Pakistan

研究点 (2)

Loading locations...

相似试验

Therapeutic Effect of Green Seaweed Against Metabloc... | 临床试验